Biotech

All Articles

A better look at Ferocious Biotech's Brutal 15

.In this full week's incident of "The Leading Pipe," our team're diving right into Fierce Biotech's ...

Lilly encounters period 2 failing of tau-targeting med

.The confetti is still soaring from Eli Lilly's event celebrating the commendation of Alzheimer's ai...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, firings as we...

Lykos will definitely ask FDA to reconsider its choice adhering to rejection of MDMA therapy for post-traumatic stress disorder

.Following a bad showing for Lykos Therapies' MDMA prospect for post-traumatic stress disorder at a ...

AN 2 fifty percents roll call, ceases phase 3 test after data disappoint

.AN2 Rehabs is actually reviewing its own organization in response to lackluster midphase informatio...

Merck pays out $700M for bispecific, snooping autoimmune position and also possibility to challenge Amgen in cancer

.Merck &amp Co. is actually spending $700 thousand in advance to challenge Amgen in a blood stream c...

Gilead pays for J&ampJ $320M to leave licensing bargain for seladelpar

.With Gilead Sciences almost an FDA decision for its own liver condition medication seladelpar, the ...

' All hands on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks may find the firms establishing outdoors tents at basecamp resp...

Entero giving up team, abandoning workplace and also stopping briefly R&ampD

.Bed Liquidators has actually transformed Entero Therapies white colored as a slab. The lender order...

Exelixis goes down ADC after choosing it's no match for Tivdak

.Exelixis is actually surrendering on its cells factor (TF)- targeting antibody-drug conjugate after...